Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.6%

5 terminated/withdrawn out of 52 trials

Success Rate

82.8%

-3.7% vs industry average

Late-Stage Pipeline

10%

5 trials in Phase 3/4

Results Transparency

4%

1 of 24 completed trials have results

Key Signals

7 recruiting1 with results

Enrollment Performance

Analytics

N/A
13(44.8%)
Phase 2
8(27.6%)
Phase 1
3(10.3%)
Phase 3
3(10.3%)
Phase 4
2(6.9%)
29Total
N/A(13)
Phase 2(8)
Phase 1(3)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials
NCT06416293Recruiting

Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and Physicians

Role: collaborator

NCT04225390Phase 2Completed

Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy

Role: collaborator

NCT07040189Not ApplicableNot Yet Recruiting

Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders

Role: collaborator

NCT05817721Completed

PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents

Role: collaborator

NCT06988345Active Not Recruiting

Juxtarenal Aortic Aneurysm

Role: collaborator

NCT05842928Not ApplicableRecruiting

Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy

Role: collaborator

NCT06323408Not Yet Recruiting

Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas

Role: lead

NCT06830421Phase 3Recruiting

Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

Role: collaborator

NCT02669069Not ApplicableCompleted

Treatment Evaluation of Neuromodulation for Tinnitus (TENT-A)

Role: collaborator

NCT03867617Phase 1Active Not Recruiting

Cell Therapy for Immunomodulation in Kidney Transplantation

Role: collaborator

NCT03032029Completed

Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation

Role: collaborator

NCT06607042Not ApplicableNot Yet Recruiting

Study on the Effectiveness of Berlin Dissexuality Therapy as Part of the Model Project in Accordance With §65d SBG V

Role: collaborator

NCT06526065Recruiting

Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)

Role: collaborator

NCT02942758Phase 2Terminated

Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML

Role: lead

NCT05880524Phase 2Not Yet Recruiting

Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)

Role: collaborator

NCT05931016Completed

Impact of Surgical Mask, FFP2 Mask and FFP3 Mask (With and Without Exhalation Valve) on Exercise Tolerance and Blood Gas Parameters of Patients With Known Lung Disease and Long-term Oxygen Therapy

Role: lead

NCT04474678Not ApplicableCompleted

Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")

Role: collaborator

NCT03563677Not ApplicableCompleted

Dual Guidance Structure for Evaluation of Patients With Unclear Diagnosis in Centers for Rare Diseases

Role: collaborator

NCT05820841Phase 3Recruiting

Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma

Role: collaborator

NCT04663828Not ApplicableCompleted

UNification of Treatments and Interventions for TInnitus Patients - Randomized Clinical Trial (UNITI-RCT)

Role: collaborator